Latest - Vaccines Safety Communication eLibrary

Jump to content

To post / rate / comment on a resource, please register first.
Existing user? Sign In
Sign In

Remember me Not recommended on shared computers

Forgot your password?
Sign Up

RESOURCES
- Most popular
- Latest
- More
COMMUNITY
ABOUT
More
- More

Home

Latest added

Questions and Answers: COVID-19 vaccines and pregnancy

Source: WHO

0 comments 991 views

LANGUAGE THAT WORKS TO IMPROVE VACCINE ACCEPTANCE-Communications Cheat Sheet

Source: Beaumont Foundation, Frank Luntz, Morning Consult

0 comments 689 views

COVID-19 and social media: best practices to reach your communities

Source: Vaccine Equity cooperative - USCDC

0 comments 427 views

Infectious Disease Memes

Source: NFID

0 comments 777 views

Influenza vaccine: frequently asked questions

Source: MVEC

0 comments 604 views

The Road to a COVID-19 Vaccine

Source: MVEC

0 comments 690 views

Allergy and immunisation

Source: MVEC

0 comments 619 views

Vaccine update - Issue 324 Special edition on Flu

Source: UK Health Security Agency

0 comments 598 views

Health Misinformation Reports and Publications

Source: HHS.gov

0 comments 362 views

How COVID-19 Viral Vector Vaccines Work

Source: VEC CHOP

0 comments 513 views

Ask the experts - Communications series

Source: National Public Health Information Coalition

0 comments 284 views

I Get It!

Source: US CDC

0 comments 225 views

Sinovac-CoronaVac COVID-19 vaccine

Source: WHO Europe

0 comments 482 views

Sinopharm COVID-19 vaccines (‎International non-proprietary name: Covilo; BIBP-CorV)

Source: WHO Europe

0 comments 502 views

Moderna COVID-19 (mRNA-1273) vaccine

Source: WHO Europe

0 comments 377 views

Janssen–Cilag International NV (‎Belgium)‎ Ad26.COV2.S COVID-19 vaccine (‎international non-proprietary name: Ad26.COV2.S COVID-19 Vaccine)

Source: WHO Europe

0 comments 634 views

Comirnaty® Pfizer/BioNTech BNT162b2 vaccine (‎international nonproprietary name: tozinameran)‎

Source: WHO Europe

0 comments 375 views

AZD1222 (ChAdOx1-S [recombinant]) COVID-19 vaccine* (International nonproprietary name: COVID-19 Vaccine (ChAdOx1-S [recombinant]))

Source: WHO Europe

0 comments 212 views

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome(TTS) following vaccination to prevent coronavirus disease (COVID-19)

Source: WHO

0 comments 300 views

COVID-19 vaccines and vaccination explained

Source: WHO CC for Vaccine Safety

0 comments 270 views

6 Ways Schools Can Promote COVID-19 Vaccination

Source: Public Health Communications collaborative

0 comments 316 views

Frequently Asked Influenza (Flu) Questions: 2021-2022 Season

Source: US CDC

0 comments 256 views

Understanding causality in adverse events after vaccination

Source: Health Feedback

0 comments 346 views

How HPV vaccine was made?

Source: Susan Nasif O-Adorisio, PhD

0 comments 1,205 views

Public Health Speaks

Source: National Public Health Information Coalition

0 comments 441 views

Aligning Public Health Communications and Immunization Programs for Greater Success Journalist Sees It

Source: National Public Health Information Coalition

0 comments 369 views

Joining the COVID-19 workforce: Education by profession

Source: IMAC

0 comments 275 views

How mRNA Vaccines Work

Source: VEC CHOP

0 comments 288 views

Catch up on checkups and routine vaccines

Source: US CDC

0 comments 311 views

Safety monitoring of COVID-19 vaccines

Source: WHO

0 comments 845 views

Thrombosis with Thrombocytopenia syndrome (TTS)

Source: MVEC

0 comments 329 views

Communicating with patients about COVID-19 vaccination - training package

Source: WHO Europe

0 comments 419 views

Vaccine Safety for Moms-To-Be

Source: US CDC

0 comments 406 views

COVID-19 State of Vaccine Confidence Insights Report

Source: US CDC

0 comments 556 views

Live Q & A on COVID-19 virus variants

Source: WHO

0 comments 319 views

Sécurité du vaccin COVID-19 : Bon à savoir

Source: Washington Department of Health

0 comments 659 views

Interactive immunisation e-learning course

Source: Public Health England

0 comments 287 views

COVID-19 COMMUNICATIONS: PROMOTING PREVENTION MEASURES AND VACCINE CONFIDENCE

Source: NFID

0 comments 367 views

What are the side effects of the Pfizer vaccine? An expert explains

Source: NCIRS

0 comments 511 views

Zoster - NCIRS fact sheets, FAQs and other resources

Source: NCIRS

0 comments 629 views

CARD

Source: Immunize Canada

0 comments 505 views

Communications Toolkit COVAX AMC_ 11June.pdf

Source: GAVI The vaccine alliance

0 comments 380 views

COVID-19 frequently asked questions

Source: NHS - UK

0 comments 395 views

Covid-19 Vaccinations Responding to vaccine hesitancy

Source: Healthy London Partnership NHS

0 comments 239 views

Find Resources & Toolkits

Source: US Department of Health and Human services

0 comments 219 views

COVID-19: Frequently asked questions. Tips and guidance for protecting your family during the COVID-19 pandemic.

Source: UNICEF

0 comments 778 views

COVID-19 Vaccines Explained in 4 Levels of Difficulty

Source: UNICEF

0 comments 783 views

Vaccination contre le Covid-19 : tout savoir sur les vaccins, la prise de rendez-vous, les doses et le calendrier de vaccination

Source: Franceinfo

0 comments 757 views

VACCINE MISINFORMATION MANAGEMENT FIELD GUIDE

Source: UNICEF, FIRST DRAFT, Yale University,

0 comments 338 views

Vaccins contre la Covid-19 : questions et réponses

Source: a Société de Pathologie Infectieuse de Langue Française

0 comments 885 views

×

RESOURCES
- Back
- RESOURCES
- Most popular
- Latest
COMMUNITY
ABOUT

×

Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines